(Q33829592)

29 July 2017

Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators (English)

1 reference

29 July 2017

1 reference

1 reference

5

Steven Alberts

1 reference

29 July 2017

Aditya Bardia

1

1 reference

29 July 2017

Charles Loprinzi

2

1 reference

29 July 2017

Axel Grothey

3

1 reference

29 July 2017

Garth Nelson

4

1 reference

29 July 2017

Smitha Menon

6

1 reference

29 July 2017

Stephan Thome

7

1 reference

29 July 2017

Sharlene Gill

8

1 reference

29 July 2017

Dan Sargent

9

1 reference

29 July 2017

language of work or name

1 reference

1 February 2010

1 reference

29 July 2017

1 reference

29 July 2017

37

1 reference

29 July 2017

39-46

1 reference

29 July 2017

1

1 reference

Decision-making for patients with resectable breast cancer: individualized decisions for and by patients and their physicians

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

Adjuvant Therapy for completely resected Stage II Colon Cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

4 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

Understanding the utility of adjuvant systemic therapy for primary breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864519

Adjuvant therapy for stage II and III colorectal cancer

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20172363

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20172363

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1053/J.SEMINONCOL.2009.12.005

1 reference

29 July 2017

1 reference

29 July 2017

1 reference